CLINICAL_TRIALS
trial_result
· 2022-01-19
Clinical Trial Update: Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma. [Phase 3]
Summary
Phase 3 trial comparing Zevalin regimen versus no further treatment in diffuse large B-cell lymphoma was terminated; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Lymphoma, Large Cell, Diffuse | Phase 3 | Status: TERMINATED | Results posted: 2022-01-19